Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-15 5:04 pm Purchase |
2025-03-31 | 13G | Ivanhoe Electric Inc. IE |
BlackRock Portfolio Management LLC | 7,849,151 5.900% |
7,849,151 (New Position) |
Filing History |
| 2025-02-14 4:45 pm Purchase |
2024-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA |
Paradigm BioCapital Advisors LP | 7,429,355 9.990% |
1,925,755 (+34.99%) |
Filing History |
| 2025-01-13 4:24 pm Sale |
2025-01-08 | 13G | Olema Pharmaceuticals, Inc. OLMA |
Bain Capital Life Sciences Opportunities IV, L.P. | 7,095,780 9.990% |
-374,434 (-5.01%) |
Filing History |
| 2024-12-11 4:30 pm Purchase |
2024-12-04 | 13G | Olema Pharmaceuticals, Inc. OLMA |
Bain Capital Life Sciences Opportunities IV, L.P. | 7,470,214 9.990% |
7,470,214 (New Position) |
Filing History |
| 2024-12-04 7:49 pm Sale |
2024-12-04 | 13D | Olema Pharmaceuticals, Inc. OLMA |
BIOTECHNOLOGY VALUE FUND L P | 7,557,237 9.990% |
-1,578,656 (-17.28%) |
Filing History |
| 2024-11-14 4:34 pm Sale |
2024-09-30 | 13G | Olema Pharmaceuticals, Inc. OLMA |
Paradigm BioCapital Advisors LP | 5,503,600 9.600% |
-2,400,000 (-30.37%) |
Filing History |
| 2024-11-14 09:20 am Purchase |
2024-09-30 | 13G | Olema Pharmaceuticals, Inc. OLMA |
Deep Track Capital, LP | 4,000,000 6.980% |
959,752 (+31.57%) |
Filing History |
| 2024-06-14 4:34 pm Purchase |
2024-06-04 | 13G | Olema Pharmaceuticals, Inc. OLMA |
Point72 Asset Management, L.P. | 3,225,250 5.700% |
3,225,250 (New Position) |
Filing History |
| 2024-06-06 6:49 pm Sale |
2024-06-04 | 13D | Olema Pharmaceuticals, Inc. OLMA |
Logos Global Management LP | 3,248,818 5.800% |
-1,018,130 (-23.86%) |
Filing History |
| 2024-03-22 4:31 pm Purchase |
2024-03-14 | 13G | Olema Pharmaceuticals, Inc. OLMA |
Deep Track Capital, LP | 3,040,248 5.440% |
3,040,248 (New Position) |
Filing History |
| 2024-02-14 4:08 pm Purchase |
2023-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA |
Paradigm BioCapital Advisors LP | 7,903,600 14.300% |
100,000 (+1.28%) |
Filing History |
| 2024-02-14 3:08 pm Purchase |
2023-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA |
Cormorant Asset Management LP | 2,456,800 4.490% |
374,800 (+18.00%) |
Filing History |
| 2024-02-14 12:53 pm Sale |
2023-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA |
Kynam Capital Management, LP | 0 0.000% |
-2,025,234 (Position Closed) |
Filing History |
| 2024-02-12 12:21 pm Sale |
2023-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA |
JANUS HENDERSON GROUP PLC JHG |
700,100 1.300% |
-2,357,206 (-77.10%) |
Filing History |
| 2024-01-29 5:25 pm Purchase |
2023-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA |
BLACKROCK INC BLK |
3,263,907 6.000% |
1,958,403 (+150.01%) |
Filing History |
| 2023-11-27 5:39 pm Purchase |
2023-09-12 | 13D | Olema Pharmaceuticals, Inc. OLMA |
Logos Global Management LP | 4,266,948 7.800% |
508,130 (+13.52%) |
Filing History |
| 2023-09-14 4:23 pm Purchase |
2023-09-12 | 13D | Olema Pharmaceuticals, Inc. OLMA |
BIOTECHNOLOGY VALUE FUND L P | 9,135,893 16.700% |
1,724,390 (+23.27%) |
Filing History |
| 2023-09-13 5:22 pm Purchase |
2023-09-12 | 13G | Olema Pharmaceuticals, Inc. OLMA |
Paradigm BioCapital Advisors LP | 7,803,600 14.300% |
5,288,489 (+210.27%) |
Filing History |
| 2023-04-10 4:33 pm Purchase |
2023-03-29 | 13G | Olema Pharmaceuticals, Inc. OLMA |
Paradigm BioCapital Advisors LP | 2,515,111 6.200% |
2,515,111 (New Position) |
Filing History |
| 2023-03-21 5:40 pm Sale |
2022-12-30 | 13G | Olema Pharmaceuticals, Inc. OLMA |
Kynam Capital Management, LP | 2,025,234 5.000% |
-38,398,598 (-94.99%) |
Filing History |